---
figid: PMC4581244__ijms-16-18270-g002
figtitle: Possible therapeutic targets in MS
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC4581244
filename: ijms-16-18270-g002.jpg
figlink: /pmc/articles/PMC4581244/figure/ijms-16-18270-f002/
number: F2
caption: Possible therapeutic targets in MS. Possible therapeutic targets in the kynurenine
  pathway—the figure displays the future drug candidates which are influencing the
  kynurenine pathway (molecules indicated in the frames) or have structural similarities
  (represented in dashed line boxes) with kynurenine metabolites.
papertitle: 'Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System
  and the Central Nervous System.'
reftext: Cecilia Rajda, et al. Int J Mol Sci. 2015 Aug;16(8):18270-18282.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8455103
figid_alias: PMC4581244__F2
figtype: Figure
redirect_from: /figures/PMC4581244__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4581244__ijms-16-18270-g002.html
  '@type': Dataset
  description: Possible therapeutic targets in MS. Possible therapeutic targets in
    the kynurenine pathway—the figure displays the future drug candidates which are
    influencing the kynurenine pathway (molecules indicated in the frames) or have
    structural similarities (represented in dashed line boxes) with kynurenine metabolites.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DLX3
  - TDO2
  - IDO1
  - KATNB1
  - F11R
  - TSTD1
  - KMO
  - anthranilic acid
  - Ro61-8048
  - laquinimod
  - teriflunomide
  - berberine
  - kynurenic acid
  - L-tryptophan
  - tryptophan
  - Trp
  - 3-hydroxyanthranilic acid
  - quinolinic acid
---
